Xspray Pharma Re-Submits its FDA Application for Dasynoc
Generic name: dasatinib Treatment for: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemi…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
文章相關商品
系統已根據文章標題、摘要和正文，自動匹配目前在售的強相關藥品。
卡博替尼片/膠囊 CABODX Cabozantinib 20/60/80mg
卡博替尼（Cabozantinib）於2012年11月29日獲FDA核准上市，用於治療進行性、轉移性甲狀腺髓樣癌;用於治療晚期腎癌;用於第二線治療晚期肝癌。 卡博替尼是一種多受體酪胺酸激酶抑制劑。卡博替尼抑制RET、肝細胞生長因子受體、血管內皮生成因子受體1(VEGFR-1 、VEGFR-2、VEGFR-3)、幹細胞生長因子受體(KIT) 、酪氨酸激酶受體(TRKB) 、FMS樣酪氨酸激酶3(FLT-3) 、AXL及上皮生長因子樣域酪氨酸激酶2(TIE-2)...
查看商品
常見問題
Which products are related to this article?
The system matched these relevant products from the article content: 盧修斯 阿昔替尼 Axitinib 線上購買、盧修斯 達沙替尼 Dasatinib 線上購買、盧修斯 卡博替尼 Cabozantinib 線上購買、卡博替尼片/膠囊 CABODX Cabozantinib 20/60/80mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
